IOLCP212.00

IOL Chemicals and Pharmaceuticals Limited

· Pharma & Health
₹ CrorePeersMOREPENLABFDCINNOVACAPORCHPHARMASENORESSANOFIGUJTHEMRPGLIFEMcap ₹6,223 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
IOLCP
FY26
MOREPENLAB
FY26
FDC
FY26
INNOVACAP
FY26
Peer
Median
Valuation — at last close
P/E45.20×66.76×20.03×47.30×47.30× -4%
P/B3.46×5.07×2.27×6.11×5.07× -32%
EV/EBITDA23.37×51.49×14.79×28.68×28.68× -18%
Market Cap₹6,223 Cr₹6,328 Cr₹5,640 Cr₹6,667 Cr₹6,328 Cr -2%
Growth
Revenue CAGR 3Y1.51%8.40%6.77%7.58% -80%
Revenue CAGR 5Y8.73%10.24%9.48%
Net Income CAGR 3Y-0.36%34.87%13.23%24.05% -101%
Revenue YoY (latest Q)37.08%34.07%2.97%33.94%33.94% +9%
Net Income YoY (latest Q)89.80%424.73%9.18%42.27%42.27% +112%
Profitability
EBITDA Margin11.60%6.96%15.94%14.90%14.90% -22%
Net Income Margin5.94%5.25%12.96%8.65%8.65% -31%
Return on Common Equity7.65%7.61%11.32%12.92%11.32% -32%
Return on Capital Employed9.95%6.17%11.23%14.73%11.23% -11%
Return on Assets5.32%4.90%9.64%7.67%7.67% -31%
Credit & Quality
Total Debt/Equity0.07×0.16×0.00×0.32×0.16× -56%
Interest Coverage12.97×5.43×57.54×11.70×11.70× +11%
Scale — latest FY
Revenue / Total Income₹2,319 Cr₹1,806 Cr₹2,171 Cr₹1,630 Cr₹1,806 Cr +28%
Net Income₹138 Cr₹94.9 Cr₹281 Cr₹141 Cr₹141 Cr -2%
Total Assets₹2,587 Cr₹1,936 Cr₹2,919 Cr₹1,837 Cr₹1,936 Cr +34%
EPS₹4.69₹1.73₹17.29₹24.63₹17.29 -73%
Book Value per Share₹61.27₹22.76₹152.64₹190.61₹152.64 -60%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.